Christopher J. Keary

636 total citations
30 papers, 345 citations indexed

About

Christopher J. Keary is a scholar working on Genetics, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Christopher J. Keary has authored 30 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 9 papers in Cognitive Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Christopher J. Keary's work include Genetic Syndromes and Imprinting (11 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Autism Spectrum Disorder Research (9 papers). Christopher J. Keary is often cited by papers focused on Genetic Syndromes and Imprinting (11 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Autism Spectrum Disorder Research (9 papers). Christopher J. Keary collaborates with scholars based in United States, Israel and Australia. Christopher J. Keary's co-authors include Christopher J. McDougle, Matcheri S. Keshavan, Dhruman D. Goradia, Nancy J. Minshew, Antonio Y. Hardan, Jennifer Mullett, Caitlin Ravichandran, Robyn P. Thom, Michelle Palumbo and Shamim H. Nejad and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Christopher J. Keary

29 papers receiving 334 citations

Peers

Christopher J. Keary
Christopher J. Keary
Citations per year, relative to Christopher J. Keary Christopher J. Keary (= 1×) peers Chuanyuan Kang

Countries citing papers authored by Christopher J. Keary

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Keary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Keary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Keary more than expected).

Fields of papers citing papers by Christopher J. Keary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Keary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Keary. The network helps show where Christopher J. Keary may publish in the future.

Co-authorship network of co-authors of Christopher J. Keary

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Keary. A scholar is included among the top collaborators of Christopher J. Keary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Keary. Christopher J. Keary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bath, Jonathan, Christopher J. Keary, Ann M. Neumeyer, et al.. (2025). Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Medicine. 23(1). 11–11. 3 indexed citations
2.
Tseng, Chieh-En Jane, Camila Canales, Jennifer Mullett, et al.. (2024). In vivo translocator protein in females with autism spectrum disorder: a pilot study. Neuropsychopharmacology. 49(7). 1193–1201. 7 indexed citations
3.
Wu, Michael C., Michelle Palumbo, Christopher J. Keary, et al.. (2024). Guanfacine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Down Syndrome: A Retrospective Chart Review. Journal of Child and Adolescent Psychopharmacology. 34(2). 95–103. 1 indexed citations
4.
Ventola, Pamela, et al.. (2023). An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study. European Journal of Paediatric Neurology. 47. 35–40. 4 indexed citations
5.
Khan, Nasreen, Raquel Cabo, Rebecca D. Burdine, et al.. (2023). Health-related quality of life and medication use among individuals with Angelman syndrome. Quality of Life Research. 32(7). 2059–2067. 3 indexed citations
6.
Keary, Christopher J., Lynne M. Bird, Marie‐Claire Y. de Wit, et al.. (2023). Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study. European Journal of Paediatric Neurology. 47. 6–12. 6 indexed citations
7.
Thom, Robyn P., Michelle Palumbo, Christopher J. Keary, et al.. (2022). Prevalence and factors associated with overweight, obesity, and hypertension in a large clinical sample of adults with autism spectrum disorder. Scientific Reports. 12(1). 9737–9737. 11 indexed citations
8.
McDougle, Christopher J., Robyn P. Thom, Caitlin Ravichandran, et al.. (2022). A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology. 47(6). 1263–1270. 15 indexed citations
9.
Thom, Robyn P., et al.. (2021). Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 52(9). 4164–4171. 4 indexed citations
10.
Keary, Christopher J., Jennifer Mullett, Lisa Nowinski, et al.. (2021). Parent Description of Anxiety in Angelman Syndrome. Journal of Autism and Developmental Disorders. 52(8). 3612–3625. 5 indexed citations
11.
Thom, Robyn P., et al.. (2021). Functional Neurological Symptom Disorder in Williams Syndrome: Case Series and Review of Relevant Literature. Journal of the Academy of Consultation-Liaison Psychiatry. 63(2). 170–179. 1 indexed citations
12.
Palumbo, Michelle, et al.. (2020). New-Onset Abnormal Vocalizations in an Adult Woman With Down Syndrome. Psychosomatics. 61(6). 804–807.
13.
Thom, Robyn P., et al.. (2020). Psychiatric Assessment of Social Impairment Across the Lifespan. Harvard Review of Psychiatry. 28(3). 159–178. 6 indexed citations
14.
O’Rourke, Julia A., Caitlin Ravichandran, Yamini J. Howe, et al.. (2019). Accuracy of self-reported history of autoimmune disease: A pilot study. PLoS ONE. 14(5). e0216526–e0216526. 15 indexed citations
15.
Thom, Robyn P., Christopher J. Keary, Michelle Palumbo, et al.. (2019). Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder. Psychopharmacology. 236(10). 3045–3061. 29 indexed citations
16.
Thom, Robyn P., Christopher J. Keary, Jessica L. Waxler, Barbara R. Pober, & Christopher J. McDougle. (2019). Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series. Journal of Autism and Developmental Disorders. 50(2). 676–682. 6 indexed citations
17.
Keary, Christopher J., Jennifer Mullett, Michelle Palumbo, et al.. (2017). Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series. Journal of Autism and Developmental Disorders. 48(3). 947–952. 6 indexed citations
18.
Sowden, Gillian L., et al.. (2016). Simulation-Based Training for Residents in the Management of Acute Agitation: A Cluster Randomized Controlled Trial. Academic Psychiatry. 41(1). 62–67. 24 indexed citations
19.
Spencer, Andrea E., Mai Uchida, Tara Kenworthy, Christopher J. Keary, & Joseph Biederman. (2014). Glutamatergic Dysregulation in Pediatric Psychiatric Disorders. The Journal of Clinical Psychiatry. 75(11). 1226–1241. 21 indexed citations
20.
Keary, Christopher J., et al.. (2009). Corpus Callosum Volume and Neurocognition in Autism. Journal of Autism and Developmental Disorders. 39(6). 834–841. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026